Reversal of an existing hearing loss by gene activation in <i>Spns2</i> mutant mice.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37552762.
- Also identified by DOI 10.1073/pnas.2307355120 and PMC identifier 10450448.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Hearing loss is highly heterogeneous, but one common form involves a failure to maintain the local ionic environment of the sensory hair cells reflected in a reduced endocochlear potential. We used a genetic approach to ask whether this type of pathology can be reversed, using the <i>Spns2<sup>tm1a</sup></i> mouse mutant known to show this defect. By activating <i>Spns2</i> gene transcription at different ages after the onset of hearing loss, we found that an existing auditory impairment can be reversed to give close to normal thresholds for an auditory brainstem response (ABR), at least at low to mid stimulus frequencies. Delaying the activation of <i>Spns2</i> led to less effective recovery of ABR thresholds, suggesting that there is a critical period for intervention. Early activation of <i>Spns2</i> not only led to improvement in auditory function but also to protection of sensory hair cells from secondary degeneration. The genetic approach we have used to establish that this type of hearing loss is in principle reversible could be extended to many other diseases using available mouse resources.
Medical subject headings
- Hearing Loss
- Anion Transport Proteins
- Genetic Therapy